Abilify News and Research

RSS
Aripiprazole (marketed as Abilify, Abilify Discmelt) is an atypical antipsychotic medication approved by the Food and Drug Administration (FDA) for the treatment of schizophrenia.
FDA approves sNDA for pediatric autism drug ABILIFY

FDA approves sNDA for pediatric autism drug ABILIFY

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Bipolar disorder drug market to decline from $6.3 billion to $5 billion

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

St. Petersburg Times examines decline in antipsychotic drug prescriptions for Florida children

St. Petersburg Times examines decline in antipsychotic drug prescriptions for Florida children

Warning about use of psychiatric drugs with the elderly

Warning about use of psychiatric drugs with the elderly

Antipsychotic drugs get FDA label changes

Antipsychotic drugs get FDA label changes

Abilify (aripiprazole) approved for acute treatment of bipolar I disorder in adolescents

Abilify (aripiprazole) approved for acute treatment of bipolar I disorder in adolescents

Drug to treat children with bipolar disorder gets priority review

Drug to treat children with bipolar disorder gets priority review

Urgent need for better understanding of bipolar disease in children and adolescents

Urgent need for better understanding of bipolar disease in children and adolescents

Bristol-Myers Squibb and Otsuka Pharmaceutical announce availability of 2 mg Abilify (aripiprazole) tablet

Bristol-Myers Squibb and Otsuka Pharmaceutical announce availability of 2 mg Abilify (aripiprazole) tablet

FDA issues public health advisory for antipsychotic drugs

FDA issues public health advisory for antipsychotic drugs

FDA wants warnings put on antipsychotic drugs

FDA wants warnings put on antipsychotic drugs

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

New and Generic Drug Approvals from FDA

New and Generic Drug Approvals from FDA